(1)
Blauvelt, A. .; Lacour, J.-P.; Toth, D.; Laquer, V.; Beissert, S.; Wollenberg, A.; Herranz, P.; Pink, A.; Peris, K. .; Fangel, S.; Saeki, H. Long-Term Improvements Observed in Tralokinumab-Treated Patients With Moderate-to-Severe Atopic Dermatitis: An ECZTEND Interim Analysis. J of Skin 2021, 5, s59.